Loading insider details...
Latest Form 4 (Jun 3, 2026): Grant/Award of 40,412 DMAC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 40,412 | n/a |
| Jun 3, 2025 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 32,162 | n/a |
| Jun 3, 2024 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 28,472 | n/a |
| Jun 16, 2023 | Replimune Group, Inc. (REPL) | Sale | 12,043 | $290.2K |
| Jun 2, 2023 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 7,493 | n/a |
| May 19, 2023 | Replimune Group, Inc. (REPL) | Sale | 12,207 | $220.3K |
| Apr 5, 2023 | Replimune Group, Inc. (REPL) | Grant/Award | 40,000 | n/a |
| Mar 6, 2023 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 26,443 | n/a |
| May 18, 2022 | Replimune Group, Inc. (REPL) | Sale | 5,473 | $79.9K |
| Apr 5, 2022 | Replimune Group, Inc. (REPL) | Grant/Award | 52,500 | n/a |